Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2015 (2015), Article ID 957574, 9 pages
http://dx.doi.org/10.1155/2015/957574
Research Article

Inhibitory Effect of Endostar on Specific Angiogenesis Induced by Human Hepatocellular Carcinoma

1Postdoctoral Station of Nanjing General Hospital, Nanjing 210002, China
2PLA Cancer Center in Eighty-One Hospital of People's Liberation Army, Nanjing 210002, China
3Department of Pathology, Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing 210008, China
4Jiangsu Harbinger Drug Development Co., Ltd., Nanjing 210002, China

Received 25 August 2014; Accepted 10 December 2014

Academic Editor: Zhongxia Wang

Copyright © 2015 Qing Ye et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Zhong, “China's expert consensus on laparoscopic liver resection and guidelines on surgical procedures: an interpretation,” Hepatobiliary Surgery and Nutrition, vol. 2, no. 4, pp. 234–235, 2013. View at Publisher · View at Google Scholar
  2. S. Farkas, C. Hackl, and H. J. Schlitt, “Overview of the indications and contraindications for liver transplantation,” Cold Spring Harbor Perspectives in Medicine, vol. 4, no. 5, Article ID a015602, 2014. View at Publisher · View at Google Scholar
  3. E. Tartour, H. Pere, B. Maillere et al., “Angiogenesis and immunity: a bidirectional link potentially relevant for the monitoring of antiangiogenic therapy and the development of novel therapeutic combination with immunotherapy,” Cancer and Metastasis Reviews, vol. 30, no. 1, pp. 83–95, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Palmowski, J. Huppert, G. Ladewig et al., “Molecular profiling of angiogenesis with targeted ultrasound imaging: early assessment of antiangiogenic therapy effects,” Molecular Cancer Therapeutics, vol. 7, no. 1, pp. 101–109, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Jiang, W.-Z. Zhang, Y. Liu et al., ““One-off” complete radiofrequency ablation for hepatocellular carcinoma in a “high-risk location” adjacent to the major bile duct and hepatic blood vessel,” Cell Biochemistry and Biophysics, vol. 69, no. 3, pp. 605–617, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. R. T.-P. Poon, I. O.-L. Ng, C. Lau et al., “Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study,” Journal of Clinical Oncology, vol. 20, no. 7, pp. 1775–1785, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. “Oral anti-angiogenesis treatment plus chemotherapy is not more efficacious than bevacizumab plus chemotherapy in metastatic colorectal cancer,” Oncology (Williston Park), vol. 25, no. 12, p. 1232, 2011.
  8. S. M. Lee, P. Baas, and H. Wakelee, “Anti-angiogenesis drugs in lung cancer,” Respirology, vol. 15, no. 3, pp. 387–392, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. C.-Y. Sang, X.-H. Xu, W.-W. Qin, J.-F. Liu, L. Hui, and S.-W. Chen, “DPMA, a deoxypodophyllotoxin derivative, induces apoptosis and anti-angiogenesis in non-small cell lung cancer A549 cells,” Bioorganic & Medicinal Chemistry Letters, vol. 23, no. 24, pp. 6650–6655, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. T. M. B. Nguyen, I. V. Subramanian, X. Xiao et al., “Endostatin induces autophagy in endothelial cells by modulating Beclin 1 and β-catenin levels,” Journal of Cellular and Molecular Medicine, vol. 13, no. 9 B, pp. 3687–3698, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. Y.-P. Chau, S.-Y. Lin, J. H.-C. Chen, and M.-H. Tai, “Endostatin induces autophagic cell death in EAhy926 human endothelial cells,” Histology and Histopathology, vol. 18, no. 3, pp. 715–726, 2003. View at Google Scholar · View at Scopus
  12. H. Wang, F. Wei, H. Li, X. Ji, S. Li, and X. Chen, “Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model,” International Journal of Molecular Medicine, vol. 31, no. 2, pp. 377–385, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. H.-F. Song, X.-W. Liu, H.-N. Zhang et al., “Pharmacokinetics of His-tag recombinant human endostatin in Rhesus monkeys,” Acta Pharmacologica Sinica, vol. 26, no. 1, pp. 124–128, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Ling, Y. Yang, N. Lu et al., “Endostar, a novel recombinant human endostatin, exerts antiangiogenic effect via blocking VEGF-induced tyrosine phosphorylation of KDR/Flk-1 of endothelial cells,” Biochemical and Biophysical Research Communications, vol. 361, no. 1, pp. 79–84, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Kim, M.-S. Park, Y. N. Park et al., “Preoperative radiologic and postoperative pathologic risk factors for early intra-hepatic recurrence in hepatocellular carcinoma patients who underwent curative resection,” Yonsei Medical Journal, vol. 50, no. 6, pp. 789–795, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. B. K. Sharma, R. Srinivasan, S. Kapil et al., “Angiogenic and anti-Angiogenic factor gene transcript level quantitation by quantitative real time PCR in patients with hepatocellular carcinoma,” Molecular Biology Reports, vol. 40, no. 10, pp. 5843–5852, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Li, Z.-L. Jin, Z.-J. Liu, J. Wang, and K. Li, “Efficacy of endostar combined with chemotherapy in multi-cycle treatment of patients with advanced non-small cell lung cancer,” Zhonghua Zhong Liu Za Zhi, vol. 33, no. 12, pp. 937–942, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. K. Javaherian, T.-Y. Lee, R. M. T. T. Sjin, G. E. Parris, and L. Hlatky, “Two endogenous antiangiogenic inhibitors, endostatin and angiostatin, demonstrate biphasic curves in their antitumor profiles,” Dose-Response, vol. 9, no. 3, pp. 369–376, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. A. Moroz, F. K. Delella, R. Almeida et al., “Finasteride inhibits human prostate cancer cell invasion through MMP2 and MMP9 downregulation,” PLoS ONE, vol. 8, no. 12, Article ID e84757, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Zeng, K. Opeskin, J. Goad, and E. D. Williams, “Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis,” Cancer Research, vol. 66, no. 19, pp. 9566–9575, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. D.-I. Sun, I. T. Nizamutdinova, Y. M. Kim et al., “Bisacurone inhibits adhesion of inflammatory monocytes or cancer cells to endothelial cells through down-regulation of VCAM-1 expression,” International Immunopharmacology, vol. 8, no. 9, pp. 1272–1281, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. S. Ghosh, M. B. Joshi, D. Ivanov et al., “Use of multicellular tumor spheroids to dissect endothelial cell-tumor cell interactions: a role for T-cadherin in tumor angiogenesis,” FEBS Letters, vol. 581, no. 23, pp. 4523–4528, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. P. Vader, R. van der Meel, M. H. Symons et al., “Examining the role of Rac1 in tumor angiogenesis and growth: a clinically relevant RNAi-mediated approach,” Angiogenesis, vol. 14, no. 4, pp. 457–466, 2011. View at Publisher · View at Google Scholar · View at Scopus
  24. M. G. Garcia, J. Bayo, M. F. Bolontrade et al., “Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo,” Molecular Pharmaceutics, vol. 8, no. 5, pp. 1538–1548, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Kolmakova, M. Rajesh, D. Zang, R. Pili, and S. Chatterjee, “VEGF recruits lactosylceramide to induce endothelial cell adhesion molecule expression and angiogenesis in vitro and in vivo,” Glycoconjugate Journal, vol. 26, no. 5, pp. 547–558, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. J. E. Holley, J. Newcombe, J. L. Whatmore, and N. J. Gutowski, “Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter,” Neuroscience Letters, vol. 470, no. 1, pp. 65–70, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Saraswati and S. S. Agarwal, “Strychnine inhibits inflammatory angiogenesis in mice via down regulation of VEGF, TNF-α and TGF-β,” Microvascular Research, vol. 87, pp. 7–13, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. K. Bentley, C. A. Franco, A. Philippides et al., “The role of differential VE-cadherin dynamics in cell rearrangement during angiogenesis,” Nature Cell Biology, vol. 16, no. 4, pp. 309–321, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. X.-N. Ma, Q.-P. Li, and Z.-C. Feng, “Research progress in cytokines and signaling pathways for promoting pulmonary angiogenesis and vascular development,” Zhongguo Dang Dai Er Ke Za Zhi, vol. 15, no. 9, pp. 800–805, 2013. View at Publisher · View at Google Scholar · View at Scopus